Heinz Ludwig
海因茨·路德维希
MD
Head, Department of Medicine I, Center for Oncology, Hematology and Palliative Care肿瘤、血液学及姑息治疗中心第一内科主任
👥Biography 个人简介
Dr. Heinz Ludwig is a pioneer in multiple myeloma treatment, especially for elderly and frail patients. His research on frailty scoring, treatment adaptation, and supportive care has shaped guidelines for managing myeloma in older adults. He is a founding contributor to the European Myeloma Network.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Myeloma in Elderly Patients
Developed frailty-adapted treatment algorithms and validated the IMWG frailty score to guide dosing and regimen selection for older myeloma patients, improving tolerability and outcomes.
Anemia Management in Myeloma
Conducted seminal studies on erythropoiesis-stimulating agents and iron supplementation in myeloma-associated anemia, establishing evidence-based supportive care guidelines.
Representative Works 代表性著作
Frailty Score in Patients with Newly Diagnosed Multiple Myeloma
Leukemia (2015)
Developed a validated frailty score enabling individualized treatment decisions and predicting survival outcomes in elderly myeloma patients.
IMWG Consensus on Maintenance Therapy in Multiple Myeloma
Blood (2017)
International consensus guidelines on maintenance therapy approaches improving long-term disease control in myeloma.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Elihu Estey
Fred Hutchinson Cancer Center
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Naval Daver
The University of Texas MD Anderson Cancer Center
Courtney DiNardo
The University of Texas MD Anderson Cancer Center
关注 海因茨·路德维希 的研究动态
Follow Heinz Ludwig's research updates
留下邮箱，当我们发布与 Heinz Ludwig（Wilhelminen Cancer Research Institute, Wilhelminenspital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment